White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Key takeaways from MedAffairs Transformation: creating a high-value medical affairs organization in the age of AI
November 9, 2026 | White Papers and Resources |
What does a high-value medical affairs organization look like in a world of constrained resources, increasingly capable artificial intelligence (AI) and easier access to scientific …
Brought to you by Amiculum
What the Most Favored Nation (MFN) policy means for UK Pharma
October 20, 2026 | White Papers and Resources |
By Jed Avissar and Manca Povsic
Brought to you by Amiculum
PharmaQuest returns: EPA perspectives, through a rare disease lens
April 7, 2026 | White Papers and Resources |
By Lottie Sequerra and Emily Morton-West
Brought to you by Amiculum
Amiculum meets Paul Tunnah: Pharma’s adoption of AI in healthcare communications
March 26, 2026 | White Papers and Resources |
By Steve Wilson
Brought to you by Amiculum
From ‘why’ to ‘how’: patient partnership across age groups in research and publications
February 27, 2026 | White Papers and Resources |
By Sarah Mohamad
Brought to you by Amiculum
Winning in Pharma: the power of early strategic planning with patients
February 17, 2026 | White Papers and Resources |
By Zoë van Helmond
Brought to you by Amiculum
Turn payer insights into impact with omnichannel engagement in market access
February 17, 2026 | White Papers and Resources |
By Betty Charleshouse
Brought to you by Amiculum
How can pharma build genuine partnerships with patient communities?
January 19, 2026 | White Papers and Resources |
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines …
Brought to you by Amiculum